Bio Protech Inc. (XKON:A199290) announced a private placement of series 8 non-guaranteed unsecured privately equity convertible bonds for the gross proceeds of KRW 540,000,000 on April 6, 2021. The transaction was approved by board of directors. The bonds does not carry a coupon rate and carries a yield to maturity of 1%. The transaction will include participation from KC-GP New Technology Association No. 1. The bonds will mature on April 06, 2024. The bonds are 100% convertible into 1,080,000 common shares at a price of KRW 500 per share from April 06, 2022 to March 07, 2024. The transaction has been approved by board of directors of the company.